Hyperlipidemia. Disorders of lipoprotein metabolism and other lipidaemias
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects were eligible if they have a total cholesterol and LDL levels between 240-200 mmol/l and 160-100 mmol/l respectively. People should not be suffering from any other diseases, including heart problems, kidney, lung, thyroid disorders, gastrointestinal, rheumatoid arthritis and other liver problems such as hepatitis or fatty liver, pregnancy or lactating, no smoking, their weight may not change fast in the last two months, should not use drugs that affect blood sugar, blood fat, blood pressure and anti-inflammatory and not to have any sensitivity to garlic and lemon juice. Individual with a history of chronic disease, consuming medicine and flowing special regimen were excluded.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total cholesterol. Timepoint: in the first of intervention and end of 8th week. Method of measurement: enzymatic, mg/dl.;Serum low-density lipoprotein cholesterol (LDL-C) levels. Timepoint: Before intervention and at the end of 8th week. Method of measurement: Enzymatic, mg/dl.;Serum hight-density lipoprotein cholesterol (HDL-C) levels. Timepoint: Before intervention and at the end of 8th week. Method of measurement: Enzymatic, mg/dl.;Triglyceride. Timepoint: in the first of intervention and end of 8th week. Method of measurement: Enzyme colorimetric methods, mg/dl.;Fibrinogen. Timepoint: Before intervention and at the end of 8th week. Method of measurement: Clauss method.;Systolic blood pressure. Timepoint: Before intervention and at the end of 8th week. Method of measurement: mmHg, Mercurial sphygmomanometer.;Diastolic blood pressure. Timepoint: Before intervention and at the end of 8th week. Method of measurement: mmHg, Mercurial sphygmomanometer.;Body mass index. Timepoint: Before intervention and at the end of 8th week. Method of measurement: kg/m2, Weight/Height squar.;Fasting blood sugar. Timepoint: Before intervention and at the end of 8th week. Method of measurement: Enzymatic, mg/dl.;Weight. Timepoint: Before intervention and at the end of 8th week. Method of measurement: Scale, kilogram. | — |
Countries
Iran (Islamic Republic of)
Contacts
Isfahan University of Medical Sciences